Overview

Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment

Status:
Terminated
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of the rotigotine transdermal patch in reducing anxiety in people with Parkinson's disease.
Phase:
Phase 4
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Institute on Aging (NIA)
Treatments:
N 0437
Rotigotine